- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Dermavance ready to launch
Berwyn, Pa. - DermAvance Pharmaceuticals, a privately heldspecialty dermatology pharmaceutical company, has appointed KeithA. Greathouse as president and chief executive officer. The companyalso announced the launch of its first products, including Vivelif,a topical therapy to address visible signs of aging.
Berwyn, Pa. - DermAvance Pharmaceuticals, a privately held specialty dermatology pharmaceutical company, has appointed Keith A. Greathouse as president and chief executive officer. The company also announced the launch of its first products, including Vivelif, a topical therapy to address visible signs of aging.
Mr. Greathouse was formerly executive vice president for Sanofi-Aventis Dermatology (Dermik).
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
